QualityDipStocks / Technology · IT services
Clarivate Plc CLVT
Outside our quality screen, so we don’t track its dips. It’s 56% below its 52-week high.
Outside our quality screen, 5% under its Market Value. No fair value estimate for now: the model’s result is too extreme to stand behind.
Worth knowing
- Lowest price in 5 years of weekly closes
From the data on this page, as of the last close. How we pick these
- Fair value est.
- n/a
- Market Value
- $1.75price −5%
- Off 52-wk high
- −56%
- Risk vs market
- Below marketbeta 0.75
52-week range 9% of the way from its 52-week low to its high
Price $1.66Market Value $1.75
5 bullish · 5 bearish See why
Repriced or dip?
Dip: business intact
The price is 56% below its 52-week high (Nov 28), but the business held up: revenue growth rate +10.7 pts, operating margin +7.1 pts, shares outstanding fewer shares, each owns more.
Some numbers held up (revenue growth rate +10.7 pts, operating margin +7.1 pts, shares outstanding fewer shares, each owns more), others slipped (revenue −4.8%). The price is 56% below its 52-week high.
The price is 56% below its 52-week high, and the business changed too: revenue −4.8%.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 9 numbers, high vs now
- Revenue, last 12 months$2.5B → $2.4B (−4.8%)changed
- Revenue growth rate−3.0% → +7.7% a year (+10.7 pts)held up
- Free cash flow, 12 months$335M → $322M (−3.8%)about the same
- Operating margin−1.3% → 5.8% (+7.1 pts)held up
- Shares outstanding−4.3% (fewer shares, each owns more)held up
- Net cash (cash minus debt)+20.8% of market cap since the highheld up
- Stock vs its sector (Technology)stock −56%, sector median +9% since Nov 28changed
- Price fall vs business numbersprice −56%, revenue/EPS/FCF median −4% (shown, not scored)
- Valuation multipleP/FCF 7.5× at the high → 3.3× now (shown, not scored)
Business numbers as reported at the high (12 months to Sep 30, 2025) vs the latest filing (12 months to Sep 30, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
At the high ($3.76, Nov 28) the price assumed about −10%/yr free-cash-flow growth; at the low ($1.45, Oct 5) about −27%; today about −25%. The last 3 years delivered 6%/yr (free cash flow).
Dashed line: what the last 3 years delivered, 6%/yr (free cash flow)
| High | Low | Now | |
|---|---|---|---|
| Price | $3.76Nov 28 | $1.45Oct 5 | $1.66 |
| Implied growth | −10% | −27% | −25% |
| P/FCF | 7.5× | 2.8× | 3.3× |
| EV/Sales | 2.6× | 2.0× | 2.1× |
What this means: the higher the implied growth, the more the price already counts on. If today's number sits well below what the business has delivered, the market expects less than its track record.
How it’s computed
Reverse DCF: the same 10-year free-cash-flow model as our fair value estimate (9.5% discount rate, growth for years 1–5 fading to 3% by year 10, 3% after), solved for the growth that makes it equal the market value at each price. For the high and the low we use only the filings that were public on that day, so nothing from a later report leaks back. Market value = that close × diluted shares. P/E = market value / 12-month net income; Price / FCF = market value / 12-month free cash flow; EV / Sales = (market value + debt − cash) / 12-month revenue. Hidden when the share count moved over 20% (split, merger), free cash flow is negative, or the company reports in another currency.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
Estimate unreliable for CLVT: the model gives 381% above the price, more than we can stand behind (usually peak-cycle cash flow, heavy debt, or cash flows that include customer or loan balances). We’d rather show nothing than a made-up number.
What the price implies To be worth today’s price, CLVT’s free cash flow would need to shrink about 25% a year for five years; our estimate uses 3%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much CLVT moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves a bit less than the market, but its own price swings are 6.0× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- 0.75
- Volatility
- 76% vs 13% SPY
- Correlation SPY
- 0.13
- Correlation QQQ
- 0.03
How it ranks
Where CLVT stands vs every one of the 2,467 stocks we cover that has the number. Longer bar = better.
Top quarter on 1 of 4 measures
- Free cash flow yield30% · free cash flow vs market capTop 1%of 1,690
- Revenue growth, last 12 months+7.7% · vs the 12 months beforeLowest 42%of 2,184
- Operating margin5.8% · of sales kept as operating profitLowest 33%of 1,549
- Return on invested capital1.3% · profit per dollar of capitalLowest 14%of 1,001
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
MV $1.75 · FCF value $17.35
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
ValuationFree-cash-flow yield of 30.4% (price / FCF 3.3×): $322M of free cash in the last 12 months.
ProfitabilityOperating margin widened to 2.9% in FY2025 from −27.9% in FY2023 (SEC filings).
Cash returnsShare count down 4.3% in a year.
ValuationEV/EBITDA of 5.6×: modest for what the business earns before interest, tax and depreciation.
ValuationTrades 5.3% below its Market Value of $1.75, the average price paid since the Oct 13 filing.
Top bearish points 5 of 5
ProfitabilityLost $386M over the last 12 months (net income, SEC filings).
Balance sheetNet debt of $3.9B, 366% of the market cap (Sep 30, 2026).
ProfitabilityReturn on invested capital of 1%, below the 9.5% discount rate our DCF uses.
GrowthSales shrank 3% a year from FY2022 to FY2025.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%; sales down vs the year-ago quarter; net debt 4.4× EBITDA (limit 3×).
All fundamentals
FCF yield 30.4% · ROE -8% · Sales +8%
Valuation
- P/E
- n/aloss over the last 12 months
- Price / FCF
- 3.3×
- FCF yield
- 30.4%
- EV / EBITDA
- 5.6×
- Price / sales
- 0.45×
- Price / book
- 0.24×
- Market cap
- $1.1Bprice × diluted shares
- Enterprise value
- $4.9B
Growth
- Revenue, 12 months
- $2.4B
- Sales growth, 12 months
- +7.7%vs the 12 months before
- Sales growth, 3 yrs
- −2.6%/yrfrom FY2022
- Diluted EPS, 12 months
- −$0.61
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- −$386M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- 67.9%
- Operating margin
- 5.8%
- Net margin
- −16.2%
- FCF margin
- 13.5%
- Return on equity
- −8%
- Return on invested capital
- 1%
Balance sheet
- Cash & short-term inv.
- $257M
- Total debt
- $4.1B
- Net cash
- −$3.9B
- Debt / equity
- 0.92×
- Interest coverage
- n/ainterest expense not tagged in SEC data
Cash flow & returns
- Free cash flow, 12 months
- $322M
- FCF growth, 12 months
- −4%
- Dividend yield
- n/ano dividend payments tagged
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- −4.3%diluted shares vs a year ago
- Stock-based comp
- $58M
Trailing 12 months to Sep 30, 2026; balance sheet at Sep 30, 2026. From Clarivate Plc’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.5B · Sales −6%
- Free cash flow, 12 months$0.5B
- Free-cash-flow yield30.4%
- Free-cash-flow margin19%
- Gross margin67%
- Operating margin6%
- Return on invested capital1%
- Return on equity−7%
- Sales growth (latest quarter vs year-ago quarter)−6%
- Net debt / EBITDA4.4×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $1.66
- 52-wk lowlowest close, 1 year$1.45−12.7%
- PriceMon Nov 2 close$1.66you are here
- Market Valueavg paid since Oct 13$1.75+5.4%
- 52-wk highhighest close, 1 year$3.76+126.5%
Momentum & 52-week range
RSI 42 · 5 days −11.2%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 3
- DateTue Nov 3, before the open
- Consensus EPS$0.16
- Year-ago EPS$0.16
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
CLVT is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Clarivate Plc in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in IT services
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.